In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen [2]

Vox Sanguinis

Volumn 86, Issue 3, 2004, Pages 201-202

  Cazenave, J P ^a   Aleil, B ^a   Wiesel, M L ^a   Laforet M ^a   Isola, H ^a  

^a Etab Francais du Sang Alsace   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 8; LACTATE DEHYDROGENASE; LACTIC ACID; PADGEM PROTEIN; PLATELET GLYCOPROTEIN V; THROMBOCYTE FACTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BACTERIAL TRANSMISSION; BLOOD TRANSFUSION; DISEASE TRANSMISSION; HUMAN; LETTER; PARASITE TRANSMISSION; PH; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE VOLUME; ULTRAVIOLET A RADIATION; VIRUS INACTIVATION; VIRUS TRANSMISSION;

BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD-BORNE PATHOGENS; CELL AGING; CELLS, CULTURED; CENTRIFUGATION; HUMANS; INFECTION CONTROL; PHOTOCHEMISTRY; PLATELET COUNT; PLATELET TRANSFUSION; PSORALENS; ULTRAVIOLET RAYS;

EID: 1942530919     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0042-9007.2004.00417.x     Document Type: Letter

References (1)

1. van Rhenen D, Gulliksson H, Cazenave, J-P, Pamphilon D, Ljungman P, Klüter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforêt M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L, euroSPRITE trial: Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003; 101:2426-2433